Modeling Strategic Decision Making and Performance Measurements at ICI Pharmaceuticals

Gerd Islei, Geoff Lockett, Barry Cox, Steve Gisbourne and Mike Stratford
Additional contact information
Gerd Islei: Manchester Business School, University of Manchester, Manchester M15 6PB, United Kingdom
Geoff Lockett: Manchester Business School, University of Manchester, Manchester M15 6PB, United Kingdom
Barry Cox: ICI Pharmaceuticals, Macclesfield, Cheshire SK10 4TG, United Kingdom
Steve Gisbourne: ICI Corporate Management Services, Wilmslow, Cheshire SK9 1QT, United Kingdom
Mike Stratford: ICI Corporate Management Services, Wilmslow, Cheshire SK9 1QT, United Kingdom

Interfaces, 1991, vol. 21, issue 6, 4-22

Abstract: Over 10 years, we have developed a DSS that is used for R&D strategic decision making at ICI for selecting research projects, monitoring portfolios, allocating resources, and terminating projects. It is based on judgmental modeling concepts that have been incorporated into a modern computer-based information system. Our DSS provides a unified analysis and reporting format that helps communication and decision making among a team of research managers. Because of its flexibility, other parts of the organization have successfully adopted it.

Keywords: industries: pharmaceutical; decision analysis: applications (search for similar items in EconPapers)
Date: 1991
References: Add references at CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://dx.doi.org/10.1287/inte.21.6.4 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:inm:orinte:v:21:y:1991:i:6:p:4-22

Access Statistics for this article

More articles in Interfaces from INFORMS Contact information at EDIRC.
Bibliographic data for series maintained by Chris Asher ().